Chaperone Research Group, Max-Planck-Institute of Psychiatry, Munich, Bavaria, Germany.
Neuropsychopharmacology. 2010 Feb;35(3):792-805. doi: 10.1038/npp.2009.188. Epub 2009 Nov 18.
Aberrant biochemical processes in the brain frequently go along with subtle shifts of the cellular epigenetic profile that might support the pathogenic progression of psychiatric disorders. Although recent reports have implied the ability of certain antidepressants and mood stabilizers to modulate epigenetic parameters, studies comparing the actions of these compounds under the same conditions are lacking. In this study, we screened amitriptyline (AMI), venlafaxine, citalopram, as well as valproic acid (VPA), carbamazepine, and lamotrigine for their potential actions on global and local epigenetic modifications in rat primary astrocytes. Among all drugs, VPA exposure evoked the strongest global chromatin modifications, including histone H3/H4 hyperacetylation, 2MeH3K9 hypomethylation, and DNA demethylation, as determined by western blot and luminometric methylation analysis, respectively. CpG demethylation occurred independently of DNA methyltransferase (DNMT) suppression. Strikingly, AMI also induced slight cytosine demethylation, paralleled by the reduction in DNMT enzymatic activity, without affecting the global histone acetylation status. Locally, VPA-induced chromatin modifications were reflected at the glutamate transporter (GLT-1) promoter as shown by bisulfite sequencing and acetylated histone H4 chromatin immunoprecipitation analysis. Distinct CpG sites in the distal part of the GLT-1 promoter were demethylated and enriched in acetylated histone H4 in response to VPA. For the first time, we could show that these changes were associated with an enhanced transcription of this astrocyte-specific gene. In contrast, AMI failed to stimulate GLT-1 transcription and to alter promoter methylation levels. In conclusion, VPA and AMI globally exerted chromatin-modulating activities using different mechanisms that divergently precipitated at an astroglial gene locus.
大脑中异常的生化过程常常伴随着细胞表观遗传特征的微妙变化,这些变化可能支持精神疾病的发病进展。尽管最近的报告暗示某些抗抑郁药和情绪稳定剂能够调节表观遗传参数,但缺乏比较这些化合物在相同条件下作用的研究。在这项研究中,我们筛选了阿米替林 (AMI)、文拉法辛、西酞普兰以及丙戊酸 (VPA)、卡马西平、和拉莫三嗪,以研究它们在原代大鼠星形胶质细胞中对整体和局部表观遗传修饰的潜在作用。在所有药物中,VPA 暴露引起的全基因组染色质修饰最强,包括组蛋白 H3/H4 乙酰化、2MeH3K9 低甲基化和 DNA 去甲基化,分别通过 Western blot 和发光甲基化分析确定。CpG 去甲基化独立于 DNA 甲基转移酶 (DNMT) 抑制。值得注意的是,AMI 也诱导了轻微的胞嘧啶去甲基化,同时降低了 DNMT 酶活性,但不影响全局组蛋白乙酰化状态。局部染色质修饰在谷氨酸转运体 (GLT-1) 启动子中得到了反映,这通过亚硫酸氢盐测序和乙酰化组蛋白 H4 染色质免疫沉淀分析得到证实。VPA 诱导的 GLT-1 启动子上的不同 CpG 位点在远端部分发生去甲基化,并富含乙酰化组蛋白 H4。这是首次证明这些变化与该星形胶质细胞特异性基因的转录增强有关。相比之下,AMI 未能刺激 GLT-1 转录,也未能改变启动子甲基化水平。总之,VPA 和 AMI 以不同的机制全局发挥染色质调节作用,这些作用在星形胶质细胞基因座上产生了不同的结果。